Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.
Lucarelli G, Rutigliano M, Sanguedolce F, Galleggiante V, Giglio A, Cagiano S, Bufo P, Maiorano E, Ribatti D, Ranieri E, Gigante M, Gesualdo L, Ferro M, de Cobelli O, Buonerba C, Di Lorenzo G, De Placido S, Palazzo S, Bettocchi C, Ditonno P, Battaglia M. Lucarelli G, et al. Among authors: bufo p. Medicine (Baltimore). 2015 Nov;94(46):e2117. doi: 10.1097/MD.0000000000002117. Medicine (Baltimore). 2015. PMID: 26579829 Free PMC article.
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.
Lucarelli G, Galleggiante V, Rutigliano M, Sanguedolce F, Cagiano S, Bufo P, Lastilla G, Maiorano E, Ribatti D, Giglio A, Serino G, Vavallo A, Bettocchi C, Selvaggi FP, Battaglia M, Ditonno P. Lucarelli G, et al. Among authors: bufo p. Oncotarget. 2015 May 30;6(15):13371-86. doi: 10.18632/oncotarget.3823. Oncotarget. 2015. PMID: 25945836 Free PMC article.
Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
Pannone G, Hindi SA, Santoro A, Sanguedolce F, Rubini C, Cincione RI, De Maria S, Tortorella S, Rocchetti R, Cagiano S, Pedicillo C, Serpico R, Lo Muzio L, Bufo P. Pannone G, et al. Among authors: bufo p. Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):79-88. doi: 10.1177/039463201102400110. Int J Immunopathol Pharmacol. 2011. PMID: 21496390 Free article.
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38.
Grossi V, Lucarelli G, Forte G, Peserico A, Matrone A, Germani A, Rutigliano M, Stella A, Bagnulo R, Loconte D, Galleggiante V, Sanguedolce F, Cagiano S, Bufo P, Trabucco S, Maiorano E, Ditonno P, Battaglia M, Resta N, Simone C. Grossi V, et al. Among authors: bufo p. Autophagy. 2015 Nov 2;11(11):2102-2113. doi: 10.1080/15548627.2015.1091910. Autophagy. 2015. PMID: 26391455 Free PMC article.
Molecular markers in bladder cancer: Novel research frontiers.
Sanguedolce F, Cormio A, Bufo P, Carrieri G, Cormio L. Sanguedolce F, et al. Among authors: bufo p. Crit Rev Clin Lab Sci. 2015;52(5):242-55. doi: 10.3109/10408363.2015.1033610. Epub 2015 Jun 8. Crit Rev Clin Lab Sci. 2015. PMID: 26053693 Review.
138 results